Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Robotic Surgical Procedures | 38 | 2026 | 222 | 21.090 |
Why?
|
| Natural Orifice Endoscopic Surgery | 25 | 2025 | 73 | 16.170 |
Why?
|
| Laparoscopy | 34 | 2026 | 542 | 14.300 |
Why?
|
| Endometriosis | 29 | 2026 | 169 | 13.520 |
Why?
|
| Hysterectomy | 18 | 2025 | 200 | 7.040 |
Why?
|
| Ureter | 6 | 2025 | 85 | 4.450 |
Why?
|
| Gynecologic Surgical Procedures | 7 | 2025 | 65 | 4.310 |
Why?
|
| Vagina | 17 | 2025 | 199 | 4.090 |
Why?
|
| Operative Time | 16 | 2026 | 199 | 4.060 |
Why?
|
| Robotics | 7 | 2023 | 102 | 3.940 |
Why?
|
| Pelvic Organ Prolapse | 6 | 2021 | 29 | 3.630 |
Why?
|
| Hysterectomy, Vaginal | 7 | 2025 | 19 | 3.340 |
Why?
|
| Leiomyoma | 6 | 2022 | 73 | 3.310 |
Why?
|
| Uterine Neoplasms | 6 | 2022 | 104 | 3.150 |
Why?
|
| Uterine Myomectomy | 5 | 2022 | 13 | 3.120 |
Why?
|
| Feasibility Studies | 10 | 2026 | 814 | 3.020 |
Why?
|
| Indocyanine Green | 5 | 2025 | 51 | 2.260 |
Why?
|
| Cerclage, Cervical | 3 | 2024 | 10 | 2.160 |
Why?
|
| Uterine Prolapse | 4 | 2020 | 22 | 1.940 |
Why?
|
| Female | 70 | 2026 | 70343 | 1.690 |
Why?
|
| Adult | 42 | 2026 | 31125 | 1.630 |
Why?
|
| Uterus | 8 | 2025 | 539 | 1.530 |
Why?
|
| Pelvic Pain | 7 | 2024 | 25 | 1.440 |
Why?
|
| Retrospective Studies | 27 | 2026 | 17633 | 1.420 |
Why?
|
| Cesarean Section | 5 | 2023 | 426 | 1.320 |
Why?
|
| Treatment Outcome | 21 | 2026 | 12852 | 1.240 |
Why?
|
| Fallopian Tubes | 3 | 2018 | 67 | 1.210 |
Why?
|
| Humans | 71 | 2026 | 130403 | 1.210 |
Why?
|
| Middle Aged | 29 | 2026 | 28395 | 1.210 |
Why?
|
| Suture Techniques | 5 | 2024 | 174 | 1.190 |
Why?
|
| Sterilization Reversal | 2 | 2018 | 5 | 1.140 |
Why?
|
| Cicatrix | 2 | 2019 | 125 | 1.080 |
Why?
|
| Sutures | 5 | 2020 | 62 | 1.050 |
Why?
|
| Blood Loss, Surgical | 4 | 2025 | 168 | 1.040 |
Why?
|
| Peritoneal Diseases | 1 | 2025 | 10 | 0.940 |
Why?
|
| Pregnancy | 16 | 2024 | 7423 | 0.940 |
Why?
|
| Fertility Preservation | 1 | 2025 | 60 | 0.870 |
Why?
|
| Postoperative Complications | 8 | 2025 | 3105 | 0.870 |
Why?
|
| Diaphragm | 1 | 2025 | 101 | 0.860 |
Why?
|
| Coloring Agents | 1 | 2024 | 70 | 0.860 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2024 | 4 | 0.840 |
Why?
|
| Ovarian Cysts | 2 | 2021 | 21 | 0.840 |
Why?
|
| Incisional Hernia | 1 | 2024 | 5 | 0.840 |
Why?
|
| Broad Ligament | 1 | 2023 | 2 | 0.780 |
Why?
|
| Obesity, Morbid | 1 | 2025 | 229 | 0.750 |
Why?
|
| Myoma | 1 | 2022 | 2 | 0.740 |
Why?
|
| Uterine Rupture | 1 | 2022 | 15 | 0.740 |
Why?
|
| Urinary Bladder Diseases | 1 | 2022 | 28 | 0.730 |
Why?
|
| Hysteroscopy | 2 | 2019 | 14 | 0.710 |
Why?
|
| Sterilization, Tubal | 2 | 2018 | 13 | 0.700 |
Why?
|
| Pregnancy, Cornual | 1 | 2021 | 1 | 0.700 |
Why?
|
| Dermoid Cyst | 1 | 2021 | 34 | 0.660 |
Why?
|
| Salpingectomy | 4 | 2024 | 15 | 0.650 |
Why?
|
| Teratoma | 1 | 2021 | 120 | 0.620 |
Why?
|
| Adnexal Diseases | 1 | 2020 | 23 | 0.620 |
Why?
|
| Colposcopy | 1 | 2019 | 17 | 0.610 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 82 | 0.590 |
Why?
|
| Stents | 1 | 2024 | 781 | 0.570 |
Why?
|
| Uterine Diseases | 2 | 2015 | 21 | 0.570 |
Why?
|
| Endoscopy | 1 | 2020 | 270 | 0.550 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2018 | 67 | 0.530 |
Why?
|
| Morcellation | 1 | 2017 | 3 | 0.520 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 455 | 0.500 |
Why?
|
| Sarcoma, Endometrial Stromal | 1 | 2015 | 2 | 0.480 |
Why?
|
| Smooth Muscle Tumor | 1 | 2015 | 2 | 0.480 |
Why?
|
| Hand-Assisted Laparoscopy | 1 | 2015 | 3 | 0.460 |
Why?
|
| Vascular Neoplasms | 1 | 2015 | 31 | 0.460 |
Why?
|
| Adenomyosis | 3 | 2023 | 13 | 0.460 |
Why?
|
| Citric Acid | 1 | 2015 | 46 | 0.450 |
Why?
|
| Organometallic Compounds | 1 | 2015 | 111 | 0.440 |
Why?
|
| Endometrium | 5 | 2025 | 280 | 0.440 |
Why?
|
| Fluorescence | 2 | 2025 | 94 | 0.440 |
Why?
|
| Heart Neoplasms | 1 | 2015 | 107 | 0.430 |
Why?
|
| Endometrial Neoplasms | 1 | 2015 | 111 | 0.420 |
Why?
|
| Ovariectomy | 3 | 2020 | 156 | 0.420 |
Why?
|
| Young Adult | 6 | 2025 | 9974 | 0.420 |
Why?
|
| Colpotomy | 3 | 2018 | 7 | 0.410 |
Why?
|
| Obesity | 1 | 2025 | 2383 | 0.410 |
Why?
|
| Preoperative Care | 1 | 2015 | 356 | 0.380 |
Why?
|
| Pilot Projects | 3 | 2024 | 1452 | 0.380 |
Why?
|
| Urogenital Abnormalities | 2 | 2024 | 159 | 0.350 |
Why?
|
| Organ Size | 2 | 2025 | 423 | 0.320 |
Why?
|
| Surgical Instruments | 2 | 2020 | 52 | 0.300 |
Why?
|
| Length of Stay | 1 | 2015 | 1393 | 0.300 |
Why?
|
| China | 3 | 2019 | 281 | 0.300 |
Why?
|
| Dissection | 3 | 2018 | 57 | 0.300 |
Why?
|
| Pelvic Floor | 2 | 2019 | 36 | 0.290 |
Why?
|
| Surgical Wound | 2 | 2019 | 21 | 0.280 |
Why?
|
| Surgical Mesh | 2 | 2019 | 64 | 0.280 |
Why?
|
| Estrogen Receptor beta | 2 | 2025 | 77 | 0.270 |
Why?
|
| Surgeons | 2 | 2025 | 286 | 0.260 |
Why?
|
| Tissue Adhesions | 2 | 2018 | 27 | 0.250 |
Why?
|
| Pain Measurement | 2 | 2018 | 350 | 0.240 |
Why?
|
| Aged | 6 | 2021 | 20899 | 0.240 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2025 | 15 | 0.230 |
Why?
|
| Douglas' Pouch | 1 | 2024 | 1 | 0.210 |
Why?
|
| Fallopian Tube Diseases | 1 | 2024 | 6 | 0.210 |
Why?
|
| Propensity Score | 1 | 2025 | 266 | 0.210 |
Why?
|
| Abortion, Habitual | 1 | 2024 | 15 | 0.210 |
Why?
|
| Wound Closure Techniques | 1 | 2024 | 25 | 0.210 |
Why?
|
| Body Mass Index | 2 | 2023 | 1682 | 0.200 |
Why?
|
| Aminopyridines | 1 | 2024 | 63 | 0.200 |
Why?
|
| Polyglactin 910 | 1 | 2023 | 4 | 0.200 |
Why?
|
| Infertility | 1 | 2024 | 73 | 0.190 |
Why?
|
| Pyrroles | 1 | 2024 | 184 | 0.190 |
Why?
|
| Learning Curve | 1 | 2022 | 54 | 0.180 |
Why?
|
| Ligaments | 1 | 2020 | 20 | 0.170 |
Why?
|
| Urinary Bladder | 1 | 2022 | 219 | 0.160 |
Why?
|
| Biological Products | 1 | 2022 | 141 | 0.160 |
Why?
|
| Cystectomy | 1 | 2021 | 141 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 768 | 0.160 |
Why?
|
| Signal Transduction | 4 | 2025 | 4649 | 0.160 |
Why?
|
| Menorrhagia | 2 | 2017 | 77 | 0.150 |
Why?
|
| Organ Sparing Treatments | 1 | 2020 | 38 | 0.150 |
Why?
|
| Hysteroscopes | 1 | 2019 | 1 | 0.150 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2020 | 60 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 614 | 0.150 |
Why?
|
| Sacrococcygeal Region | 1 | 2019 | 36 | 0.150 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2019 | 32 | 0.150 |
Why?
|
| Pregnancy Complications | 1 | 2024 | 535 | 0.150 |
Why?
|
| Hysterosalpingography | 1 | 2018 | 6 | 0.140 |
Why?
|
| Quality of Life | 2 | 2019 | 2070 | 0.140 |
Why?
|
| Methylene Blue | 1 | 2018 | 17 | 0.140 |
Why?
|
| Umbilicus | 1 | 2018 | 13 | 0.140 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 4015 | 0.140 |
Why?
|
| Cystocele | 1 | 2018 | 2 | 0.140 |
Why?
|
| Pelvic Floor Disorders | 1 | 2018 | 12 | 0.140 |
Why?
|
| Microsurgery | 1 | 2018 | 65 | 0.140 |
Why?
|
| Urinary Incontinence | 1 | 2018 | 69 | 0.140 |
Why?
|
| Endosonography | 1 | 2018 | 76 | 0.140 |
Why?
|
| Apoptosis | 1 | 2024 | 1840 | 0.130 |
Why?
|
| Muscle Contraction | 1 | 2018 | 146 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6773 | 0.130 |
Why?
|
| Cilia | 1 | 2018 | 75 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 249 | 0.130 |
Why?
|
| Abdomen | 1 | 2018 | 129 | 0.130 |
Why?
|
| Gestational Age | 1 | 2021 | 1223 | 0.130 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2016 | 6 | 0.120 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2018 | 194 | 0.120 |
Why?
|
| Choristoma | 1 | 2016 | 47 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 465 | 0.120 |
Why?
|
| Iliac Vein | 1 | 2015 | 28 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2018 | 296 | 0.120 |
Why?
|
| Linear Models | 1 | 2017 | 689 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3805 | 0.120 |
Why?
|
| Cathartics | 1 | 2015 | 29 | 0.110 |
Why?
|
| Enema | 1 | 2015 | 46 | 0.110 |
Why?
|
| Wound Healing | 1 | 2019 | 476 | 0.110 |
Why?
|
| Vena Cava, Inferior | 1 | 2015 | 95 | 0.110 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 154 | 0.100 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2025 | 150 | 0.100 |
Why?
|
| Heart Atria | 1 | 2015 | 333 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2015 | 757 | 0.080 |
Why?
|
| Adolescent | 2 | 2021 | 20731 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2019 | 5084 | 0.080 |
Why?
|
| Time Factors | 1 | 2019 | 6183 | 0.070 |
Why?
|
| Animals | 5 | 2025 | 33852 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5204 | 0.070 |
Why?
|
| Mice | 4 | 2025 | 18180 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2017 | 6447 | 0.060 |
Why?
|
| Infant | 1 | 2021 | 13276 | 0.060 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 21 | 0.050 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 27 | 0.050 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2025 | 154 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2024 | 306 | 0.050 |
Why?
|
| Interferons | 1 | 2024 | 136 | 0.050 |
Why?
|
| Beclin-1 | 1 | 2023 | 33 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2024 | 126 | 0.050 |
Why?
|
| Iridoid Glucosides | 1 | 2022 | 4 | 0.050 |
Why?
|
| Decidua | 1 | 2024 | 139 | 0.050 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 132 | 0.050 |
Why?
|
| Stromal Cells | 1 | 2024 | 307 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2025 | 592 | 0.040 |
Why?
|
| Cell Survival | 1 | 2024 | 836 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 582 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2024 | 453 | 0.040 |
Why?
|
| Child | 1 | 2021 | 26159 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 863 | 0.040 |
Why?
|
| Fertility | 1 | 2022 | 256 | 0.040 |
Why?
|
| Estrogens | 1 | 2022 | 430 | 0.040 |
Why?
|
| Autophagy | 1 | 2023 | 421 | 0.040 |
Why?
|
| DNA | 1 | 2024 | 1411 | 0.040 |
Why?
|
| Stem Cells | 1 | 2023 | 711 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 142 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3812 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2024 | 2467 | 0.030 |
Why?
|
| Dysmenorrhea | 1 | 2016 | 13 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 1331 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 4654 | 0.030 |
Why?
|
| Reproduction | 1 | 2016 | 213 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 4698 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 890 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3408 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2343 | 0.020 |
Why?
|
| Male | 1 | 2022 | 64486 | 0.010 |
Why?
|